G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillPodcast
![]() |
Hear G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences. |
News
Biotechs claw for their lifeblood - financing November 17, 2008 | Press Release
Biotech Visionary, G. Steven Burrill receives DiNA November 14, 2008 | Press Release
Redpoint Bio Retains Burrill & Co. to Advise on Strategic Alternatives November 12, 2008 | Press Release
See all NewsThe Stem Cell Report and Stem Cell Summit Webcast (DVD Price)
There is no doubt that we are on the cusp of major stem cell breakthroughs. Stem cells will one day provide effective low-cost treatment for diabetes, some forms of blindness, heart attack, stroke, spinal cord damage and many other health problems. Animal stem cell studies are already very promising and some clinical trials using stem cells have been initiated. The Burrill Stem Cell Report provides a comprehensive look at the latest research taking place around the world. Some of our featured articles include
- The role of academic research centers in stem cell research
- Stem cells and small molecule screening for diverse therapeutics
- Stem cells and diabetes
- Validation of stem cell lines
- Patenting stem cells technology
- Stem Cell research in Asia, Australia and Canada
Articles in The Stem Cell Report include:
- Stem Cells 101
- POLICY & ADVOCACY
- The Science Lobby—Speaking Truth to Power
- Ready for Prime Time? American Journalism and the Stem Cell Wars
- The Rise of the Pro-Cures Movement
- Executive Order 13435: Recasting the Debate?
- Human Eggs: The Need, the Risks, the Politics
- FUNDING & SUPPORT
- Private Philanthropy: Freedom from Bureaucracy
- The Role of Academic Research Centers in Stem Cell Research
- Australia and the Global Stem Cell Village
- GLOBAL VIEW
- The State of Stem Cell Research in Asia in the Post-Hwang Era
- The Big Cell: How The Stem Cell Network Created a Unique Legacy for Canada’s Research Community
- Serious Stem Cell Research is Happening in Australia
- The U.K.: A Comprehensive Regulatory Framework for Regenerative Medicine
- SCIENCE
- The HSCI Therapeutic Screening Center: Stem Cells and Small Molecule
- Screening for Diverse Therapeutics
- Turning Back The Developmental Clock: Directly Reprogrammed Fibroblasts Are Indistinguishable From Embryonic Stem Cells
- The Development of a Cell-Based Cure for Type I Diabetes
- A Gut Reaction to Stem Cell Therapy for Diabetes
- A Multidisciplinary Approach to Stem Cells and Diabetes
- Modifying Stem Cells for Clinical Regenerative Applications: A Practical Approach to a Fundamental Problem in Translational Research
- Defined Media and Surfaces for Feeder-Independent Culture of Human Embryonic Stem Cells
- LAW
- Patent Protection for Stem Cells in a Changing Scientific and Legal Environment
- Patenting Stem Cell Technology: The First 120 Feet
- REGISTRIES
- The National Stem Cell Bank: A Scientific Treasure for the Future
- Validation of Stem Cell Lines
- Current and Proposed Stem Cell Registries: An International Perspective
- COMMERCIALIZATION
- Commentary: Technological Trajectories and Stem Cell “Dominant Design”
- A Conversation with Geoff MacKay
- The Multi-Lineage Progenitor Cell: An Enabling Tool for Developing Cellular and Biologic Therapies
- Australia’s Emergence as a Major Stem Cell Player
- Is Long-Term Autologous Adult Stem Cell Banking a New Form of Insurance?
- Welcome and meeting overview | Industry Overview
- How Stem Cell Research Will Transform Medicine in the 21 Century
- Keynote Presentation: Stem Cell Research: A Patient’s Perspective
- Keynote Presentation: A Case Study of Private Philanthropic Support for Stem Cell Research and Advocacy
- Panel Discussion: The Promise of SCNT and Reprogramming
- Panel Discussion: The Global Perspective on Stem Cell Research
- Panel Discussion: Stem Cell Nation
- Panel Discussion: The Hospital Perspective-An HSCI Case Study
- Panel Discussion: Investing in Stem Cell Research – the VC Perspective
- Panel Discussion: Investing in Stem Cell Research – the Biotechnology Perspective
- Panel Discussion: Taking Research from the Labs to the Clinic: Legal, Translational and Regulatory Challenges for Stem Cell Companies
- Balancing Global Regulation to Enhance Global Collaboration
Add to cart$495.00

.jpg)
.jpg)